Addressing the silent threat: managing invasive Candida infections in hospitalized newborns

Invasive fungal infections (IFIs) remain an important problem for hospitalized newborn infants receiving intensive care, given their substantial morbidity and mortality. Candida species (Candida spp.) are the major fungal pathogens, which cause the so-called invasive Candida infections (ICIs). Of th...

Full description

Saved in:
Bibliographic Details
Main Authors: Deshuang Zhang, Dongke Xie, Haokun Yuan, Na He, Wenbin Dong, Xiaoping Lei
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2025.1613832/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849318354522734592
author Deshuang Zhang
Deshuang Zhang
Dongke Xie
Haokun Yuan
Na He
Wenbin Dong
Xiaoping Lei
author_facet Deshuang Zhang
Deshuang Zhang
Dongke Xie
Haokun Yuan
Na He
Wenbin Dong
Xiaoping Lei
author_sort Deshuang Zhang
collection DOAJ
description Invasive fungal infections (IFIs) remain an important problem for hospitalized newborn infants receiving intensive care, given their substantial morbidity and mortality. Candida species (Candida spp.) are the major fungal pathogens, which cause the so-called invasive Candida infections (ICIs). Of these, Candida albicans is the most commonly isolated species, followed by Candida parapsilosis. Other identified Candida spp. include Candida glabrata, Candida tropicalis, Candida krusei, etc. However, an increasing shift in the epidemiology of ICIs worldwide has been described, non-albicans Candida (NAC) spp. ICIs pose a growing threat to neonates. Herein, we examine the epidemiology of Candida spp. infections, patterns of antifungal resistance, risk factors, prevention strategies, clinical outcomes, and treatment recommendations for ICIs in hospitalized newborn infants. This review aims to provide a thorough understanding of the current evidence on ICIs to better inform targeted prevention strategies and improved treatments to reduce neonatal morbidity and mortality.
format Article
id doaj-art-817d1a94f8cc4334a0efced710542bba
institution Kabale University
issn 2296-2360
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj-art-817d1a94f8cc4334a0efced710542bba2025-08-20T03:50:53ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602025-07-011310.3389/fped.2025.16138321613832Addressing the silent threat: managing invasive Candida infections in hospitalized newbornsDeshuang Zhang0Deshuang Zhang1Dongke Xie2Haokun Yuan3Na He4Wenbin Dong5Xiaoping Lei6Department of Neonatology, Children’s Medical Center, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, ChinaDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, ChinaDepartment of Pediatric Surgery, Children’s Medical Center, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, ChinaDepartment of Neonatology, Children’s Medical Center, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, ChinaDepartment of Neonatology, Children’s Medical Center, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, ChinaDepartment of Neonatology, Children’s Medical Center, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, ChinaDepartment of Neonatology, Children’s Medical Center, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, ChinaInvasive fungal infections (IFIs) remain an important problem for hospitalized newborn infants receiving intensive care, given their substantial morbidity and mortality. Candida species (Candida spp.) are the major fungal pathogens, which cause the so-called invasive Candida infections (ICIs). Of these, Candida albicans is the most commonly isolated species, followed by Candida parapsilosis. Other identified Candida spp. include Candida glabrata, Candida tropicalis, Candida krusei, etc. However, an increasing shift in the epidemiology of ICIs worldwide has been described, non-albicans Candida (NAC) spp. ICIs pose a growing threat to neonates. Herein, we examine the epidemiology of Candida spp. infections, patterns of antifungal resistance, risk factors, prevention strategies, clinical outcomes, and treatment recommendations for ICIs in hospitalized newborn infants. This review aims to provide a thorough understanding of the current evidence on ICIs to better inform targeted prevention strategies and improved treatments to reduce neonatal morbidity and mortality.https://www.frontiersin.org/articles/10.3389/fped.2025.1613832/fullantifungal resistanceinvasive Candida infections (ICIs)newborn infantspathogensprevention strategiesrisk factors
spellingShingle Deshuang Zhang
Deshuang Zhang
Dongke Xie
Haokun Yuan
Na He
Wenbin Dong
Xiaoping Lei
Addressing the silent threat: managing invasive Candida infections in hospitalized newborns
Frontiers in Pediatrics
antifungal resistance
invasive Candida infections (ICIs)
newborn infants
pathogens
prevention strategies
risk factors
title Addressing the silent threat: managing invasive Candida infections in hospitalized newborns
title_full Addressing the silent threat: managing invasive Candida infections in hospitalized newborns
title_fullStr Addressing the silent threat: managing invasive Candida infections in hospitalized newborns
title_full_unstemmed Addressing the silent threat: managing invasive Candida infections in hospitalized newborns
title_short Addressing the silent threat: managing invasive Candida infections in hospitalized newborns
title_sort addressing the silent threat managing invasive candida infections in hospitalized newborns
topic antifungal resistance
invasive Candida infections (ICIs)
newborn infants
pathogens
prevention strategies
risk factors
url https://www.frontiersin.org/articles/10.3389/fped.2025.1613832/full
work_keys_str_mv AT deshuangzhang addressingthesilentthreatmanaginginvasivecandidainfectionsinhospitalizednewborns
AT deshuangzhang addressingthesilentthreatmanaginginvasivecandidainfectionsinhospitalizednewborns
AT dongkexie addressingthesilentthreatmanaginginvasivecandidainfectionsinhospitalizednewborns
AT haokunyuan addressingthesilentthreatmanaginginvasivecandidainfectionsinhospitalizednewborns
AT nahe addressingthesilentthreatmanaginginvasivecandidainfectionsinhospitalizednewborns
AT wenbindong addressingthesilentthreatmanaginginvasivecandidainfectionsinhospitalizednewborns
AT xiaopinglei addressingthesilentthreatmanaginginvasivecandidainfectionsinhospitalizednewborns